SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $139,521,000 | -22.7% | 807,361 | -48.6% | 0.05% | -22.7% |
Q4 2014 | $180,520,000 | +308.0% | 1,570,559 | +454.6% | 0.07% | +288.2% |
Q3 2014 | $44,242,000 | +278.9% | 283,176 | +199.2% | 0.02% | +240.0% |
Q2 2014 | $11,675,000 | -45.3% | 94,648 | -54.0% | 0.01% | -44.4% |
Q1 2014 | $21,338,000 | +159.4% | 205,937 | +125.1% | 0.01% | +200.0% |
Q4 2013 | $8,226,000 | +87.3% | 91,467 | +39.3% | 0.00% | +50.0% |
Q3 2013 | $4,391,000 | -32.8% | 65,648 | -33.6% | 0.00% | -33.3% |
Q2 2013 | $6,538,000 | – | 98,844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |